ORAMED PHARMACEUTICALS INC. Shareholders' Equity
ORAMED PHARMACEUTICALS INC. (ORMP) had Shareholders' Equity of $199.74 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-03-26
- 2025-12-31: Stockholders' Equity Attributable to Parent $199.74M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $203.28M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $154.53M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $140.81M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-12-31 | $199.74M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $203.28M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $154.53M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $140.81M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $146.26M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $156.44M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $177.06M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $166.64M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $163.82M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $149.13M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $151.55M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $150.97M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $151.81M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $153.81M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $153.70M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $162.35M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $166.45M 10-K · filed 2023-03-06 | |
| 2021-11-30 | $170.16M 10-Q · filed 2022-01-11 | |
| 2021-08-31 | $115.77M 10-QT · filed 2022-03-30 | |
| 2021-05-31 | $68.12M 10-Q · filed 2021-07-14 | |
| 2021-02-28 | $49.44M 10-Q · filed 2021-04-13 | |
| 2020-11-30 | $28.21M 10-Q · filed 2021-04-13 | |
| 2020-08-31 | $32.88M 10-K · filed 2021-11-24 | |
| 2020-05-31 | $34.11M 10-Q · filed 2020-07-07 | |
| 2020-02-29 | $16.09M 10-Q · filed 2020-07-07 | |
| 2019-11-30 | $17.16M 10-Q · filed 2021-04-13 | |
| 2019-08-31 | $19.39M 10-Q · filed 2021-04-13 | |
| 2019-05-31 | $21.56M 10-Q · filed 2020-07-07 | |
| 2019-02-28 | $25.35M 10-Q · filed 2020-07-07 | |
| 2018-11-30 | $28.86M 10-Q · filed 2020-04-06 | |
| 2018-08-31 | $31.11M 10-K · filed 2020-11-24 | |
| 2018-05-31 | $16.66M 10-Q · filed 2019-07-10 | |
| 2018-02-28 | $20.48M 10-Q · filed 2019-07-10 | |
| 2017-11-30 | $22.74M 10-Q · filed 2019-01-14 | |
| 2017-08-31 | $19.24M 10-K · filed 2019-11-27 | |
| 2017-05-31 | $19.81M 10-Q · filed 2017-07-06 | |
| 2017-02-28 | $21.32M 10-Q · filed 2017-04-05 | |
| 2016-11-30 | $23.99M 10-Q · filed 2017-01-11 | |
| 2016-08-31 | $26.19M 10-K · filed 2019-11-27 | |
| 2016-05-31 | $30.98M 10-Q · filed 2016-07-06 | |
| 2016-02-29 | $32.70M 10-Q · filed 2016-04-06 | |
| 2015-11-30 | $22.54M 10-Q · filed 2016-01-13 | |
| 2015-08-31 | $24.83M 10-K · filed 2018-11-28 | |
| 2015-05-31 | $21.33M 10-Q · filed 2015-07-01 | |
| 2015-02-28 | $22.34M 10-Q · filed 2015-04-03 | |
| 2014-11-30 | $23.70M 10-Q · filed 2015-01-08 | |
| 2014-08-31 | $20.79M 10-K · filed 2017-11-29 | |
| 2014-05-31 | $21.97M 10-Q · filed 2014-07-14 | |
| 2014-02-28 | $23.33M 10-Q · filed 2014-04-10 | |
| 2013-11-30 | $7.31M 10-Q · filed 2014-01-14 | |
| 2013-08-31 | $8.13M 10-K · filed 2016-11-25 | $8.13M 10-K · filed 2013-11-27 |
| 2013-05-31 | $4.16M 10-Q · filed 2013-07-17 | |
| 2013-02-28 | $5.25M 10-Q · filed 2013-04-11 | |
| 2012-11-30 | $6.25M 10-Q · filed 2012-12-26 | |
| 2012-08-31 | $3.78M 10-K · filed 2016-11-25 | $3.78M 10-K · filed 2012-12-12 |
| 2012-05-31 | $1.97M 10-Q · filed 2012-07-12 | |
| 2012-02-29 | $2.40M 10-Q · filed 2012-04-04 | |
| 2011-11-30 | $3.32M 10-Q · filed 2012-01-12 | |
| 2011-08-31 | $3.72M 10-K · filed 2014-11-14 | $3.72M 10-Q · filed 2012-01-12 |
| 2010-08-31 | $830.27K 10-Q · filed 2014-04-10 | |
| 2009-08-31 | $2.75M 10-Q · filed 2014-04-10 | |
| 2008-08-31 | $4.59M 10-Q · filed 2014-04-10 | |
| 2007-08-31 | $513.13K 10-Q · filed 2014-04-10 | |
| 2002-04-11 | $53.70K 10-Q · filed 2014-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |